Paul S Covington insider trades: Furiex Pharmaceuticals (FURX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 24, 2014 | FURX | ↓ Sell | 10,368 | $104.12 | $1.1M | Direct | Jun 26, 2014 (2d) |
| Jun 18, 2014 | FURX | ↓ Sell | 45,691 | $104.11 | $4.8M | Direct | Jun 20, 2014 (2d) |
| Jun 13, 2014 | FURX | ↓ Sell | 3,228 | $104.25 | $337K | Direct | Jun 17, 2014 (4d) |
| Jun 10, 2014 | FURX | ↓ Sell | 2,872 | $104.63 | $300K | Direct | Jun 12, 2014 (2d) |
| Sep 10, 2013 | FURX | ↓ Sell | 30,000 | $40.89 | $1.2M | Direct | Sep 12, 2013 (2d) |
| Dec 5, 2011 | FURX | ↑ Buy | 2,850 | $17.68 | $50K | Direct | Dec 7, 2011 (2d) |
| Feb 28, 2008 | PPDI | ↓ Sell | 26,470 | $46.83 | $1.2M | Direct | Feb 29, 2008 (1d) |
| Feb 28, 2008 | PPDI | ↓ Sell | 10,196 | $46.95 | $479K | Direct | Feb 29, 2008 (1d) |
| Feb 26, 2008 | PPDI | ↓ Sell | 25,000 | $47.01 | $1.2M | Direct | Feb 28, 2008 (2d) |
| Aug 29, 2007 | PPDI | ↓ Sell | 9,045 | $35.09 | $317K | Direct | Aug 29, 2007 (0d) |
| May 29, 2007 | PPDI | ↓ Sell | 40,084 | $35.18 | $1.4M | Direct | May 30, 2007 (1d) |
| Feb 23, 2006 | PPDI | ↓ Sell | 25,834 | $69.32 | $1.8M | Direct | Feb 24, 2006 (1d) |
| Aug 23, 2005 | PPDI | ↓ Sell | 50,000 | $55.19 | $2.8M | Direct | Aug 24, 2005 (1d) |
| Aug 22, 2005 | PPDI | ↓ Sell | 13,333 | $55.51 | $740K | Direct | Aug 23, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Paul S Covington's insider trades
Paul S Covington is Senior VP-Clinical Operations at Furiex Pharmaceuticals (FURX). Since Aug 22, 2005, Paul has reported 1 open-market purchase worth $50K and 13 sales worth $17.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (9 filings), grants and awards (8 filings), other transactions (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FURX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.